Our Services

End-to-end Drug Discovery and Development solutions designed to accelerate innovation and drive growth, from bench to market.

Strategic Solutions for Start-ups, CROs, Academic and growing Pharma, empowering progress from discovery through commercialization.

Consultation
Services

R&D-as-a-Service (RaaS): Offer tailored, preclinical-to-clinical solutions, with flexible models.
Pipeline/Portfolio Optimization: Enhance asset and portfolio value through indication repurposing, therapeutic area expansion and prioritization frameworks.
Regulatory Strategy: Guide regulatory submissions, compliance, and site preparedness to ensure smooth progression to clinical trials.
Partnership and Licensing Support: Assist in structuring and evaluating in-licensing and out-licensing opportunities, while enabling collaborations that accelerate growth and market positioning.

Surface Plasmon Resonance Services:
- Kinetic interpretation tied to MOA and modality
- Go / no-go and prioritization decisions
- Integration with IDD and consultation outputs
- Study design aligned to program stage
Translational & Biomarker Platforms
Tools and models that connect target modulation to biological response, including pharmacodynamic markers and early translatability signals.
Connect with us for specialized research solutions

Innovation Assessment & Acceleration: Evaluate and advance promising scientific breakthroughs, from target identification till candidate nomination.
Support for Early Innovators: Provide scientific and regulatory guidance to help startups and researchers progress toward the clinic, including IND-enabling studies
Clinical Strategy & Execution: Design and implement clinical strategies with expertise in protocol development, biomarker planning, and site support.
Collaborative Partnerships: Work jointly with CROs, academic groups, and early-stage biotechs to co-develop and deliver impactful drug discovery programs.